FOLIFER

This brand name is authorized in Brazil, Cyprus, Hong Kong, Malta

Active ingredients

The drug FOLIFER contains a combination of these active pharmaceutical ingredients (APIs):

1 Ferrous sulfate UNII E1UOL152H7 - IRON

Iron sulphate is a co-factor of various enzymes necessary for the transfer of energy (eg. cytochrome oxidase, xanthine oxidase). Iron is also present in hemoglobin and myoglobin, which are essential for the transport and use of oxygen. Read about Ferrous sulfate

2 Folic acid UNII 935E97BOY8 - FOLIC ACID

Folic acid is a member of the vitamin B group which is reduced in the body to tetrahydrofolate, a co-enzyme active in several metabolic processes and produces a haemopoietic response in nutritional megaloblastic anaemias. Folic acid is rapidly absorbed and widely distributed in body tissues. Read about Folic acid

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
FOLIFER Film-coated tablet		MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
B03AD03	Ferrous sulfate and folic acid	B Blood and blood forming organs → B03 Antianemic preparations → B03A Iron preparations → B03AD Iron in combination with folic acid
Discover more medicines within B03AD03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 560818020002708, 560818020002808, 560818020002908, 560818020003008
Country: HK	Department of Health Drug Office	Identifier(s): 43342
Country: MT	Medicines Authority	Identifier(s): MA004/00301